Search GWLL
GOLDENWELL BIOTECH, INC.
OTC · CIK 1800373
Last close0.69
Daily change-0.00 (-0.00%)
10 Years gain+133.80%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
GWLL · STANDARD
SIC 2000 · Food and Kindred Products · Fiscal year end 1231
Fundamental
16.5Momentum
n/aAcceleration
n/aConfidence
75.0Annual Revenue7
Quarterly Revenue25
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality6.8 / 25
Capital Efficiency9.7 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Key Metrics
Revenue Growth TTMn/aINSUFFICIENT_HISTORY
Revenue CAGR 3Y-89.52%OK
Gross Margin21.82%OK
Operating Margin-208,729.09%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $55.00 | $12.00 | -$113,326.00 | -$22,629.00 | n/a | 21.82% | -206,047.27% | n/a | n/a | 99M |
| 2025 FY Dec 31, 2024 | $139.00 | $64.00 | -$123,098.00 | -$123,077.00 | n/a | 46.04% | -88,559.71% | n/a | -125.72% | 99M |
| 2024 FY Dec 31, 2023 | n/a | $666.00 | -$115,826.00 | -$113,153.00 | n/a | n/a | n/a | n/a | n/a | 99M |
| 2023 FY Dec 31, 2023 | $2,340.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| 2023 FY Dec 31, 2022 | $47,800.00 | $25,186.00 | -$985,105.00 | -$1.07M | n/a | 52.69% | -2,060.89% | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $55.00 | sum latest 4 fiscal quarters Revenue | OK | 0001477932-25-008837, 0001477932-26-004130 |
| Revenue Growth TTM | n/a | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | INSUFFICIENT_HISTORY | 0001477932-25-008837, 0001477932-26-004130 |
| Revenue CAGR 3Y | -89.52% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001477932-26-004130 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001477932-26-004130 |
| Gross Profit CAGR 3Y | -92.19% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001477932-26-004130 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001477932-26-004067, 0001477932-26-004130 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.82% | Gross Profit / Revenue | OK | 0001477932-25-008837, 0001477932-26-004130 |
| Operating Margin | -208,729.09% | Operating Income / Revenue | OK | 0001477932-25-008837, 0001477932-26-004130 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001477932-26-005067 |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001477932-25-008837, 0001477932-26-004130 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001477932-26-004130 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001477932-26-005067 |